Global Cardiovascular Diseases Stem Cell Therapy Supply, Demand and Key Producers, 2024-2030

Description

Stem cells have the ability to treat sick veins when they touch the sick vein wall. They're also used to treat heart failure by turning into heart muscle cells if there is weakness in the heart muscles. They accelerates the post-operative recovery process by reinforcing the autoimmune system. They accelerate the treatment of heart muscle inflammation and inflammation. Endothelial stem cells (treating veins) are used for vessel walls. These stem cells are mostly derived from bone marrow. However, mesenchymal or fetal stem cells are used together to treat other factors affecting the disease.

The global Cardiovascular Diseases Stem Cell Therapy market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

This report studies the global Cardiovascular Diseases Stem Cell Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cardiovascular Diseases Stem Cell Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cardiovascular Diseases Stem Cell Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Cardiovascular Diseases Stem Cell Therapy total market, 2019-2030, (USD Million)
Global Cardiovascular Diseases Stem Cell Therapy total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Cardiovascular Diseases Stem Cell Therapy total market, key domestic companies, and share, (USD Million)
Global Cardiovascular Diseases Stem Cell Therapy revenue by player, revenue and market share 2019-2024, (USD Million)
Global Cardiovascular Diseases Stem Cell Therapy total market by Type, CAGR, 2019-2030, (USD Million)
Global Cardiovascular Diseases Stem Cell Therapy total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Cardiovascular Diseases Stem Cell Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pharmicell, Gencell, BlueRock Therapeutics, Cellino Biotech, Mesoblast, BioCardia, Cedars-Sinai, Stem Cells Transplant Institute, CCTRN, Help Therapeutics Co., Ltd., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Cardiovascular Diseases Stem Cell Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Cardiovascular Diseases Stem Cell Therapy Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Cardiovascular Diseases Stem Cell Therapy Market, Segmentation by Type
    Autologous
    Allogeneic

Global Cardiovascular Diseases Stem Cell Therapy Market, Segmentation by Application:
    Preclinical
    Clinical Phase 1,2

Companies Profiled:
    Pharmicell
    Gencell
    BlueRock Therapeutics
    Cellino Biotech
    Mesoblast
    BioCardia
    Cedars-Sinai
    Stem Cells Transplant Institute
    CCTRN
    Help Therapeutics Co., Ltd.
    Beijing Cellapy biotechnology Co., LTD
    CardioCell
    Heartseed
    EmCell

Key Questions Answered
1. How big is the global Cardiovascular Diseases Stem Cell Therapy market?
2. What is the demand of the global Cardiovascular Diseases Stem Cell Therapy market?
3. What is the year over year growth of the global Cardiovascular Diseases Stem Cell Therapy market?
4. What is the total value of the global Cardiovascular Diseases Stem Cell Therapy market?
5. Who are the Major Players in the global Cardiovascular Diseases Stem Cell Therapy market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Cardiovascular Diseases Stem Cell Therapy Introduction
    1.2 World Cardiovascular Diseases Stem Cell Therapy Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Cardiovascular Diseases Stem Cell Therapy Total Market by Region (by Headquarter Location)
        1.3.1 World Cardiovascular Diseases Stem Cell Therapy Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Based Company Cardiovascular Diseases Stem Cell Therapy Revenue (2019-2030)
        1.3.3 China Based Company Cardiovascular Diseases Stem Cell Therapy Revenue (2019-2030)
        1.3.4 Europe Based Company Cardiovascular Diseases Stem Cell Therapy Revenue (2019-2030)
        1.3.5 Japan Based Company Cardiovascular Diseases Stem Cell Therapy Revenue (2019-2030)
        1.3.6 South Korea Based Company Cardiovascular Diseases Stem Cell Therapy Revenue (2019-2030)
        1.3.7 ASEAN Based Company Cardiovascular Diseases Stem Cell Therapy Revenue (2019-2030)
        1.3.8 India Based Company Cardiovascular Diseases Stem Cell Therapy Revenue (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Cardiovascular Diseases Stem Cell Therapy Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Major Market Trends

2 Demand Summary
    2.1 World Cardiovascular Diseases Stem Cell Therapy Consumption Value (2019-2030)
    2.2 World Cardiovascular Diseases Stem Cell Therapy Consumption Value by Region
        2.2.1 World Cardiovascular Diseases Stem Cell Therapy Consumption Value by Region (2019-2024)
        2.2.2 World Cardiovascular Diseases Stem Cell Therapy Consumption Value Forecast by Region (2025-2030)
    2.3 United States Cardiovascular Diseases Stem Cell Therapy Consumption Value (2019-2030)
    2.4 China Cardiovascular Diseases Stem Cell Therapy Consumption Value (2019-2030)
    2.5 Europe Cardiovascular Diseases Stem Cell Therapy Consumption Value (2019-2030)
    2.6 Japan Cardiovascular Diseases Stem Cell Therapy Consumption Value (2019-2030)
    2.7 South Korea Cardiovascular Diseases Stem Cell Therapy Consumption Value (2019-2030)
    2.8 ASEAN Cardiovascular Diseases Stem Cell Therapy Consumption Value (2019-2030)
    2.9 India Cardiovascular Diseases Stem Cell Therapy Consumption Value (2019-2030)

3 World Cardiovascular Diseases Stem Cell Therapy Companies Competitive Analysis
    3.1 World Cardiovascular Diseases Stem Cell Therapy Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Cardiovascular Diseases Stem Cell Therapy Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Cardiovascular Diseases Stem Cell Therapy in 2023
        3.2.3 Global Concentration Ratios (CR8) for Cardiovascular Diseases Stem Cell Therapy in 2023
    3.3 Cardiovascular Diseases Stem Cell Therapy Company Evaluation Quadrant
    3.4 Cardiovascular Diseases Stem Cell Therapy Market: Overall Company Footprint Analysis
        3.4.1 Cardiovascular Diseases Stem Cell Therapy Market: Region Footprint
        3.4.2 Cardiovascular Diseases Stem Cell Therapy Market: Company Product Type Footprint
        3.4.3 Cardiovascular Diseases Stem Cell Therapy Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
    4.1 United States VS China: Cardiovascular Diseases Stem Cell Therapy Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Cardiovascular Diseases Stem Cell Therapy Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Cardiovascular Diseases Stem Cell Therapy Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Cardiovascular Diseases Stem Cell Therapy Consumption Value Comparison
        4.2.1 United States VS China: Cardiovascular Diseases Stem Cell Therapy Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Cardiovascular Diseases Stem Cell Therapy Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Cardiovascular Diseases Stem Cell Therapy Companies and Market Share, 2019-2024
        4.3.1 United States Based Cardiovascular Diseases Stem Cell Therapy Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Cardiovascular Diseases Stem Cell Therapy Revenue, (2019-2024)
    4.4 China Based Companies Cardiovascular Diseases Stem Cell Therapy Revenue and Market Share, 2019-2024
        4.4.1 China Based Cardiovascular Diseases Stem Cell Therapy Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Cardiovascular Diseases Stem Cell Therapy Revenue, (2019-2024)
    4.5 Rest of World Based Cardiovascular Diseases Stem Cell Therapy Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Cardiovascular Diseases Stem Cell Therapy Companies, Headquarters (Province, Country)
        4.5.2 Rest of World Based Companies Cardiovascular Diseases Stem Cell Therapy Revenue (2019-2024)

5 Market Analysis by Type
    5.1 World Cardiovascular Diseases Stem Cell Therapy Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Autologous
        5.2.2 Allogeneic
    5.3 Market Segment by Type
        5.3.1 World Cardiovascular Diseases Stem Cell Therapy Market Size by Type (2019-2024)
        5.3.2 World Cardiovascular Diseases Stem Cell Therapy Market Size by Type (2025-2030)
        5.3.3 World Cardiovascular Diseases Stem Cell Therapy Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
    6.1 World Cardiovascular Diseases Stem Cell Therapy Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Preclinical
        6.2.2 Clinical Phase 1,2
    6.3 Market Segment by Application
        6.3.1 World Cardiovascular Diseases Stem Cell Therapy Market Size by Application (2019-2024)
        6.3.2 World Cardiovascular Diseases Stem Cell Therapy Market Size by Application (2025-2030)
        6.3.3 World Cardiovascular Diseases Stem Cell Therapy Market Size Market Share by Application (2019-2030)

7 Company Profiles
    7.1 Pharmicell
        7.1.1 Pharmicell Details
        7.1.2 Pharmicell Major Business
        7.1.3 Pharmicell Cardiovascular Diseases Stem Cell Therapy Product and Services
        7.1.4 Pharmicell Cardiovascular Diseases Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Pharmicell Recent Developments/Updates
        7.1.6 Pharmicell Competitive Strengths & Weaknesses
    7.2 Gencell
        7.2.1 Gencell Details
        7.2.2 Gencell Major Business
        7.2.3 Gencell Cardiovascular Diseases Stem Cell Therapy Product and Services
        7.2.4 Gencell Cardiovascular Diseases Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Gencell Recent Developments/Updates
        7.2.6 Gencell Competitive Strengths & Weaknesses
    7.3 BlueRock Therapeutics
        7.3.1 BlueRock Therapeutics Details
        7.3.2 BlueRock Therapeutics Major Business
        7.3.3 BlueRock Therapeutics Cardiovascular Diseases Stem Cell Therapy Product and Services
        7.3.4 BlueRock Therapeutics Cardiovascular Diseases Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 BlueRock Therapeutics Recent Developments/Updates
        7.3.6 BlueRock Therapeutics Competitive Strengths & Weaknesses
    7.4 Cellino Biotech
        7.4.1 Cellino Biotech Details
        7.4.2 Cellino Biotech Major Business
        7.4.3 Cellino Biotech Cardiovascular Diseases Stem Cell Therapy Product and Services
        7.4.4 Cellino Biotech Cardiovascular Diseases Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Cellino Biotech Recent Developments/Updates
        7.4.6 Cellino Biotech Competitive Strengths & Weaknesses
    7.5 Mesoblast
        7.5.1 Mesoblast Details
        7.5.2 Mesoblast Major Business
        7.5.3 Mesoblast Cardiovascular Diseases Stem Cell Therapy Product and Services
        7.5.4 Mesoblast Cardiovascular Diseases Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Mesoblast Recent Developments/Updates
        7.5.6 Mesoblast Competitive Strengths & Weaknesses
    7.6 BioCardia
        7.6.1 BioCardia Details
        7.6.2 BioCardia Major Business
        7.6.3 BioCardia Cardiovascular Diseases Stem Cell Therapy Product and Services
        7.6.4 BioCardia Cardiovascular Diseases Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 BioCardia Recent Developments/Updates
        7.6.6 BioCardia Competitive Strengths & Weaknesses
    7.7 Cedars-Sinai
        7.7.1 Cedars-Sinai Details
        7.7.2 Cedars-Sinai Major Business
        7.7.3 Cedars-Sinai Cardiovascular Diseases Stem Cell Therapy Product and Services
        7.7.4 Cedars-Sinai Cardiovascular Diseases Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Cedars-Sinai Recent Developments/Updates
        7.7.6 Cedars-Sinai Competitive Strengths & Weaknesses
    7.8 Stem Cells Transplant Institute
        7.8.1 Stem Cells Transplant Institute Details
        7.8.2 Stem Cells Transplant Institute Major Business
        7.8.3 Stem Cells Transplant Institute Cardiovascular Diseases Stem Cell Therapy Product and Services
        7.8.4 Stem Cells Transplant Institute Cardiovascular Diseases Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Stem Cells Transplant Institute Recent Developments/Updates
        7.8.6 Stem Cells Transplant Institute Competitive Strengths & Weaknesses
    7.9 CCTRN
        7.9.1 CCTRN Details
        7.9.2 CCTRN Major Business
        7.9.3 CCTRN Cardiovascular Diseases Stem Cell Therapy Product and Services
        7.9.4 CCTRN Cardiovascular Diseases Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 CCTRN Recent Developments/Updates
        7.9.6 CCTRN Competitive Strengths & Weaknesses
    7.10 Help Therapeutics Co., Ltd.
        7.10.1 Help Therapeutics Co., Ltd. Details
        7.10.2 Help Therapeutics Co., Ltd. Major Business
        7.10.3 Help Therapeutics Co., Ltd. Cardiovascular Diseases Stem Cell Therapy Product and Services
        7.10.4 Help Therapeutics Co., Ltd. Cardiovascular Diseases Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Help Therapeutics Co., Ltd. Recent Developments/Updates
        7.10.6 Help Therapeutics Co., Ltd. Competitive Strengths & Weaknesses
    7.11 Beijing Cellapy biotechnology Co., LTD
        7.11.1 Beijing Cellapy biotechnology Co., LTD Details
        7.11.2 Beijing Cellapy biotechnology Co., LTD Major Business
        7.11.3 Beijing Cellapy biotechnology Co., LTD Cardiovascular Diseases Stem Cell Therapy Product and Services
        7.11.4 Beijing Cellapy biotechnology Co., LTD Cardiovascular Diseases Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Beijing Cellapy biotechnology Co., LTD Recent Developments/Updates
        7.11.6 Beijing Cellapy biotechnology Co., LTD Competitive Strengths & Weaknesses
    7.12 CardioCell
        7.12.1 CardioCell Details
        7.12.2 CardioCell Major Business
        7.12.3 CardioCell Cardiovascular Diseases Stem Cell Therapy Product and Services
        7.12.4 CardioCell Cardiovascular Diseases Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 CardioCell Recent Developments/Updates
        7.12.6 CardioCell Competitive Strengths & Weaknesses
    7.13 Heartseed
        7.13.1 Heartseed Details
        7.13.2 Heartseed Major Business
        7.13.3 Heartseed Cardiovascular Diseases Stem Cell Therapy Product and Services
        7.13.4 Heartseed Cardiovascular Diseases Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Heartseed Recent Developments/Updates
        7.13.6 Heartseed Competitive Strengths & Weaknesses
    7.14 EmCell
        7.14.1 EmCell Details
        7.14.2 EmCell Major Business
        7.14.3 EmCell Cardiovascular Diseases Stem Cell Therapy Product and Services
        7.14.4 EmCell Cardiovascular Diseases Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 EmCell Recent Developments/Updates
        7.14.6 EmCell Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Cardiovascular Diseases Stem Cell Therapy Industry Chain
    8.2 Cardiovascular Diseases Stem Cell Therapy Upstream Analysis
    8.3 Cardiovascular Diseases Stem Cell Therapy Midstream Analysis
    8.4 Cardiovascular Diseases Stem Cell Therapy Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Cardiovascular Diseases Stem Cell Therapy Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Table 2. World Cardiovascular Diseases Stem Cell Therapy Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
 Table 3. World Cardiovascular Diseases Stem Cell Therapy Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
 Table 4. World Cardiovascular Diseases Stem Cell Therapy Revenue Market Share by Region (2019-2024), (by Headquarter Location)
 Table 5. World Cardiovascular Diseases Stem Cell Therapy Revenue Market Share by Region (2025-2030), (by Headquarter Location)
 Table 6. Major Market Trends
 Table 7. World Cardiovascular Diseases Stem Cell Therapy Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
 Table 8. World Cardiovascular Diseases Stem Cell Therapy Consumption Value by Region (2019-2024) & (USD Million)
 Table 9. World Cardiovascular Diseases Stem Cell Therapy Consumption Value Forecast by Region (2025-2030) & (USD Million)
 Table 10. World Cardiovascular Diseases Stem Cell Therapy Revenue by Player (2019-2024) & (USD Million)
 Table 11. Revenue Market Share of Key Cardiovascular Diseases Stem Cell Therapy Players in 2023
 Table 12. World Cardiovascular Diseases Stem Cell Therapy Industry Rank of Major Player, Based on Revenue in 2023
 Table 13. Global Cardiovascular Diseases Stem Cell Therapy Company Evaluation Quadrant
 Table 14. Head Office of Key Cardiovascular Diseases Stem Cell Therapy Players
 Table 15. Cardiovascular Diseases Stem Cell Therapy Market: Company Product Type Footprint
 Table 16. Cardiovascular Diseases Stem Cell Therapy Market: Company Product Application Footprint
 Table 17. Cardiovascular Diseases Stem Cell Therapy Mergers & Acquisitions Activity
 Table 18. United States VS China Cardiovascular Diseases Stem Cell Therapy Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 19. United States VS China Cardiovascular Diseases Stem Cell Therapy Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 20. United States Based Cardiovascular Diseases Stem Cell Therapy Companies, Headquarters (States, Country)
 Table 21. United States Based Companies Cardiovascular Diseases Stem Cell Therapy Revenue, (2019-2024) & (USD Million)
 Table 22. United States Based Companies Cardiovascular Diseases Stem Cell Therapy Revenue Market Share (2019-2024)
 Table 23. China Based Cardiovascular Diseases Stem Cell Therapy Companies, Headquarters (Province, Country)
 Table 24. China Based Companies Cardiovascular Diseases Stem Cell Therapy Revenue, (2019-2024) & (USD Million)
 Table 25. China Based Companies Cardiovascular Diseases Stem Cell Therapy Revenue Market Share (2019-2024)
 Table 26. Rest of World Based Cardiovascular Diseases Stem Cell Therapy Companies, Headquarters (Province, Country)
 Table 27. Rest of World Based Companies Cardiovascular Diseases Stem Cell Therapy Revenue (2019-2024) & (USD Million)
 Table 28. Rest of World Based Companies Cardiovascular Diseases Stem Cell Therapy Revenue Market Share (2019-2024)
 Table 29. World Cardiovascular Diseases Stem Cell Therapy Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Table 30. World Cardiovascular Diseases Stem Cell Therapy Market Size Value by Type (2019-2024) & (USD Million)
 Table 31. World Cardiovascular Diseases Stem Cell Therapy Market Size by Type (2025-2030) & (USD Million)
 Table 32. World Cardiovascular Diseases Stem Cell Therapy Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Table 33. World Cardiovascular Diseases Stem Cell Therapy Market Size by Application (2019-2024) & (USD Million)
 Table 34. World Cardiovascular Diseases Stem Cell Therapy Market Size by Application (2025-2030) & (USD Million)
 Table 35. Pharmicell Basic Information, Manufacturing Base and Competitors
 Table 36. Pharmicell Major Business
 Table 37. Pharmicell Cardiovascular Diseases Stem Cell Therapy Product and Services
 Table 38. Pharmicell Cardiovascular Diseases Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 39. Pharmicell Recent Developments/Updates
 Table 40. Pharmicell Competitive Strengths & Weaknesses
 Table 41. Gencell Basic Information, Manufacturing Base and Competitors
 Table 42. Gencell Major Business
 Table 43. Gencell Cardiovascular Diseases Stem Cell Therapy Product and Services
 Table 44. Gencell Cardiovascular Diseases Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 45. Gencell Recent Developments/Updates
 Table 46. Gencell Competitive Strengths & Weaknesses
 Table 47. BlueRock Therapeutics Basic Information, Manufacturing Base and Competitors
 Table 48. BlueRock Therapeutics Major Business
 Table 49. BlueRock Therapeutics Cardiovascular Diseases Stem Cell Therapy Product and Services
 Table 50. BlueRock Therapeutics Cardiovascular Diseases Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 51. BlueRock Therapeutics Recent Developments/Updates
 Table 52. BlueRock Therapeutics Competitive Strengths & Weaknesses
 Table 53. Cellino Biotech Basic Information, Manufacturing Base and Competitors
 Table 54. Cellino Biotech Major Business
 Table 55. Cellino Biotech Cardiovascular Diseases Stem Cell Therapy Product and Services
 Table 56. Cellino Biotech Cardiovascular Diseases Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 57. Cellino Biotech Recent Developments/Updates
 Table 58. Cellino Biotech Competitive Strengths & Weaknesses
 Table 59. Mesoblast Basic Information, Manufacturing Base and Competitors
 Table 60. Mesoblast Major Business
 Table 61. Mesoblast Cardiovascular Diseases Stem Cell Therapy Product and Services
 Table 62. Mesoblast Cardiovascular Diseases Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 63. Mesoblast Recent Developments/Updates
 Table 64. Mesoblast Competitive Strengths & Weaknesses
 Table 65. BioCardia Basic Information, Manufacturing Base and Competitors
 Table 66. BioCardia Major Business
 Table 67. BioCardia Cardiovascular Diseases Stem Cell Therapy Product and Services
 Table 68. BioCardia Cardiovascular Diseases Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 69. BioCardia Recent Developments/Updates
 Table 70. BioCardia Competitive Strengths & Weaknesses
 Table 71. Cedars-Sinai Basic Information, Manufacturing Base and Competitors
 Table 72. Cedars-Sinai Major Business
 Table 73. Cedars-Sinai Cardiovascular Diseases Stem Cell Therapy Product and Services
 Table 74. Cedars-Sinai Cardiovascular Diseases Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 75. Cedars-Sinai Recent Developments/Updates
 Table 76. Cedars-Sinai Competitive Strengths & Weaknesses
 Table 77. Stem Cells Transplant Institute Basic Information, Manufacturing Base and Competitors
 Table 78. Stem Cells Transplant Institute Major Business
 Table 79. Stem Cells Transplant Institute Cardiovascular Diseases Stem Cell Therapy Product and Services
 Table 80. Stem Cells Transplant Institute Cardiovascular Diseases Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 81. Stem Cells Transplant Institute Recent Developments/Updates
 Table 82. Stem Cells Transplant Institute Competitive Strengths & Weaknesses
 Table 83. CCTRN Basic Information, Manufacturing Base and Competitors
 Table 84. CCTRN Major Business
 Table 85. CCTRN Cardiovascular Diseases Stem Cell Therapy Product and Services
 Table 86. CCTRN Cardiovascular Diseases Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 87. CCTRN Recent Developments/Updates
 Table 88. CCTRN Competitive Strengths & Weaknesses
 Table 89. Help Therapeutics Co., Ltd. Basic Information, Manufacturing Base and Competitors
 Table 90. Help Therapeutics Co., Ltd. Major Business
 Table 91. Help Therapeutics Co., Ltd. Cardiovascular Diseases Stem Cell Therapy Product and Services
 Table 92. Help Therapeutics Co., Ltd. Cardiovascular Diseases Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 93. Help Therapeutics Co., Ltd. Recent Developments/Updates
 Table 94. Help Therapeutics Co., Ltd. Competitive Strengths & Weaknesses
 Table 95. Beijing Cellapy biotechnology Co., LTD Basic Information, Manufacturing Base and Competitors
 Table 96. Beijing Cellapy biotechnology Co., LTD Major Business
 Table 97. Beijing Cellapy biotechnology Co., LTD Cardiovascular Diseases Stem Cell Therapy Product and Services
 Table 98. Beijing Cellapy biotechnology Co., LTD Cardiovascular Diseases Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 99. Beijing Cellapy biotechnology Co., LTD Recent Developments/Updates
 Table 100. Beijing Cellapy biotechnology Co., LTD Competitive Strengths & Weaknesses
 Table 101. CardioCell Basic Information, Manufacturing Base and Competitors
 Table 102. CardioCell Major Business
 Table 103. CardioCell Cardiovascular Diseases Stem Cell Therapy Product and Services
 Table 104. CardioCell Cardiovascular Diseases Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 105. CardioCell Recent Developments/Updates
 Table 106. CardioCell Competitive Strengths & Weaknesses
 Table 107. Heartseed Basic Information, Manufacturing Base and Competitors
 Table 108. Heartseed Major Business
 Table 109. Heartseed Cardiovascular Diseases Stem Cell Therapy Product and Services
 Table 110. Heartseed Cardiovascular Diseases Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 111. Heartseed Recent Developments/Updates
 Table 112. Heartseed Competitive Strengths & Weaknesses
 Table 113. EmCell Basic Information, Manufacturing Base and Competitors
 Table 114. EmCell Major Business
 Table 115. EmCell Cardiovascular Diseases Stem Cell Therapy Product and Services
 Table 116. EmCell Cardiovascular Diseases Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 117. EmCell Recent Developments/Updates
 Table 118. EmCell Competitive Strengths & Weaknesses
 Table 119. Global Key Players of Cardiovascular Diseases Stem Cell Therapy Upstream (Raw Materials)
 Table 120. Global Cardiovascular Diseases Stem Cell Therapy Typical Customers


List of Figures
 Figure 1. Cardiovascular Diseases Stem Cell Therapy Picture
 Figure 2. World Cardiovascular Diseases Stem Cell Therapy Total Revenue: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Cardiovascular Diseases Stem Cell Therapy Total Revenue (2019-2030) & (USD Million)
 Figure 4. World Cardiovascular Diseases Stem Cell Therapy Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Figure 5. World Cardiovascular Diseases Stem Cell Therapy Revenue Market Share by Region (2019-2030), (by Headquarter Location)
 Figure 6. United States Based Company Cardiovascular Diseases Stem Cell Therapy Revenue (2019-2030) & (USD Million)
 Figure 7. China Based Company Cardiovascular Diseases Stem Cell Therapy Revenue (2019-2030) & (USD Million)
 Figure 8. Europe Based Company Cardiovascular Diseases Stem Cell Therapy Revenue (2019-2030) & (USD Million)
 Figure 9. Japan Based Company Cardiovascular Diseases Stem Cell Therapy Revenue (2019-2030) & (USD Million)
 Figure 10. South Korea Based Company Cardiovascular Diseases Stem Cell Therapy Revenue (2019-2030) & (USD Million)
 Figure 11. ASEAN Based Company Cardiovascular Diseases Stem Cell Therapy Revenue (2019-2030) & (USD Million)
 Figure 12. India Based Company Cardiovascular Diseases Stem Cell Therapy Revenue (2019-2030) & (USD Million)
 Figure 13. Cardiovascular Diseases Stem Cell Therapy Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World Cardiovascular Diseases Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 16. World Cardiovascular Diseases Stem Cell Therapy Consumption Value Market Share by Region (2019-2030)
 Figure 17. United States Cardiovascular Diseases Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 18. China Cardiovascular Diseases Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 19. Europe Cardiovascular Diseases Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 20. Japan Cardiovascular Diseases Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 21. South Korea Cardiovascular Diseases Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 22. ASEAN Cardiovascular Diseases Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 23. India Cardiovascular Diseases Stem Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 24. Producer Shipments of Cardiovascular Diseases Stem Cell Therapy by Player Revenue ($MM) and Market Share (%): 2023
 Figure 25. Global Four-firm Concentration Ratios (CR4) for Cardiovascular Diseases Stem Cell Therapy Markets in 2023
 Figure 26. Global Four-firm Concentration Ratios (CR8) for Cardiovascular Diseases Stem Cell Therapy Markets in 2023
 Figure 27. United States VS China: Cardiovascular Diseases Stem Cell Therapy Revenue Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Cardiovascular Diseases Stem Cell Therapy Consumption Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. World Cardiovascular Diseases Stem Cell Therapy Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Figure 30. World Cardiovascular Diseases Stem Cell Therapy Market Size Market Share by Type in 2023
 Figure 31. Autologous
 Figure 32. Allogeneic
 Figure 33. World Cardiovascular Diseases Stem Cell Therapy Market Size Market Share by Type (2019-2030)
 Figure 34. World Cardiovascular Diseases Stem Cell Therapy Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Figure 35. World Cardiovascular Diseases Stem Cell Therapy Market Size Market Share by Application in 2023
 Figure 36. Preclinical
 Figure 37. Clinical Phase 1,2
 Figure 38. World Cardiovascular Diseases Stem Cell Therapy Market Size Market Share by Application (2019-2030)
 Figure 39. Cardiovascular Diseases Stem Cell Therapy Industrial Chain
 Figure 40. Methodology
 Figure 41. Research Process and Data Source

Companies Mentioned

Pharmicell
Gencell
BlueRock Therapeutics
Cellino Biotech
Mesoblast
BioCardia
Cedars-Sinai
Stem Cells Transplant Institute
CCTRN
Help Therapeutics Co., Ltd.
Beijing Cellapy biotechnology Co., LTD
CardioCell
Heartseed
EmCell